Discover how Yokogawa’s Tri-Integrity model integrates quality management, manufacturing operations, and laboratory processes across pharmaceutical organizations. By connecting eQMS, MES, and LIMS, Tri-Integrity supports the FDA's Quality Management Maturity (QMM) framework, helping pharmaceutical companies identify the optimal investments to reduce the cost of poor quality, improve compliance, and ensure data integrity throughout the pharmaceutical value chain.
Stroscio Alessandro
Solution Architect LIFE EU, Yokogawa Europe
Alessandro Stroscio's expertise spans Manufacturing Execution Systems (MES), Quality Management Systems (QMS), Laboratory Information Management Systems (LIMS), Serialization, and Smart Manufacturing initiatives for pharmaceutical and other regulated industries. He supports the deployment of Yokogawa's Tri-Integrity framework, which integrates quality, manufacturing, and laboratory operations to advance Quality Management Maturity. He is actively involved in both pre-sales and project delivery activities, helping pharmaceutical manufacturers define and execute their digital transformation and Pharma 5.0 roadmaps.